Prostate Cancer Prevention

Prostate cancer was the most common male malignancy and a leading cause of cancer death among men in the West. The article reviewed various prevention strategies, including dietary fat reduction, supplementation with vitamins D and E, selenium, soy, green tea, and lycopene-rich products. It also examined pharmacological interventions like cyclo-oxygenase inhibitors, antiestrogens, and 5-alpha reductase inhibitors, highlighting the Prostate Cancer Prevention Trial and the controversy over higher-grade cancers with finasteride. The article noted that prostate cancer prevention was extensively researched, with definitive answers from pivotal phase 3 trials expected within 2 to 7 years.